GB201209986D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB201209986D0 GB201209986D0 GBGB1209986.7A GB201209986A GB201209986D0 GB 201209986 D0 GB201209986 D0 GB 201209986D0 GB 201209986 A GB201209986 A GB 201209986A GB 201209986 D0 GB201209986 D0 GB 201209986D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1209986.7A GB201209986D0 (en) | 2012-06-06 | 2012-06-06 | Novel compounds |
US14/124,516 US9193704B2 (en) | 2011-06-07 | 2012-06-07 | Hydantoin derivatives as KV3 inhibitors |
JP2014514148A JP6008953B2 (en) | 2011-06-07 | 2012-06-07 | Hydantoin derivatives as KV3 inhibitors |
PCT/GB2012/051278 WO2012168710A1 (en) | 2011-06-07 | 2012-06-07 | Hydantoin derivates as kv3 inhibitors |
CN201280027811.XA CN103596943B (en) | 2011-06-07 | 2012-06-07 | Hydantoin derivatives as KV3 inhibitor |
EP12726849.8A EP2718285B1 (en) | 2011-06-07 | 2012-06-07 | Hydantoin derivatives as kv3 inhibitors |
BR112013031402A BR112013031402A2 (en) | 2011-06-07 | 2012-06-07 | hydantoin derivatives as kv3 inhibitors |
PCT/GB2013/051343 WO2013175211A1 (en) | 2012-05-22 | 2013-05-22 | Hydantoin derivatives as kv3 inhibitors |
US14/403,011 US9669030B2 (en) | 2012-05-22 | 2013-05-22 | Hydantoin derivatives as Kv3 inhibitors |
BR112014028718A BR112014028718A2 (en) | 2012-05-22 | 2013-05-22 | hydantoin derivatives as kv3 inhibitors |
EP13725443.9A EP2852588B8 (en) | 2012-05-22 | 2013-05-22 | Hydantoin derivatives as kv3 inhibitors |
JP2015513268A JP2015517563A (en) | 2012-05-22 | 2013-05-22 | Hydantoin derivatives as KV3 inhibitors |
CN201380026712.4A CN104334548A (en) | 2012-05-22 | 2013-05-22 | Hydantoin derivatives as kv3 inhibitors |
PCT/GB2013/051488 WO2013182851A1 (en) | 2012-06-06 | 2013-06-06 | Prophylaxis or treatment of diseases where a modulator of kv3.3 channels is required |
PCT/GB2013/051487 WO2013182850A1 (en) | 2012-06-06 | 2013-06-06 | Isobenzofuran- 5 -yl-oxy- (hetero) aryl - imidazolidine - 2, 4 -dione derivatives modulators of kv3 potassium channels for the treatment of cns disorders. |
IN2409KON2014 IN2014KN02409A (en) | 2012-05-22 | 2014-10-29 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1209986.7A GB201209986D0 (en) | 2012-06-06 | 2012-06-06 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201209986D0 true GB201209986D0 (en) | 2012-07-18 |
Family
ID=46582363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1209986.7A Ceased GB201209986D0 (en) | 2011-06-07 | 2012-06-06 | Novel compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201209986D0 (en) |
WO (1) | WO2013182850A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9193704B2 (en) | 2011-06-07 | 2015-11-24 | Autifony Therapeutics Limited | Hydantoin derivatives as KV3 inhibitors |
US9669030B2 (en) | 2012-05-22 | 2017-06-06 | Autifony Therapeutics Limited | Hydantoin derivatives as Kv3 inhibitors |
JP6240667B2 (en) | 2012-05-22 | 2017-11-29 | アウトイフオンイ トヘラペウトイクス リミテッド | Triazoles as KV3 inhibitors |
GB201521751D0 (en) | 2015-12-10 | 2016-01-27 | Autifony Therapeutics Ltd | Novel uses |
KR20210076081A (en) | 2018-10-16 | 2021-06-23 | 오티포니 세라피틱스 리미티드 | novel compound |
US20220204489A1 (en) * | 2019-04-26 | 2022-06-30 | H. Lundbeck A/S | ARYLSULFONYLTHIOPHENECARBOXAMIDES AND ARYLSULFONYLFURANCARBOXAMIDES AS Kv3 POTASSIUM CHANNEL ACTIVATORS |
JP2023523501A (en) | 2020-02-06 | 2023-06-06 | アウトイフオンイ トヘラペウトイクス リミテッド | KV3 modulator |
CN117751119A (en) | 2021-08-10 | 2024-03-22 | 奥蒂福尼疗法有限公司 | Potassium channel modulators |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101735675B1 (en) | 2009-12-11 | 2017-05-15 | 오티포니 세라피틱스 리미티드 | Imidazolidinedione derivatives |
WO2012076877A1 (en) | 2010-12-06 | 2012-06-14 | Autifony Therapeutics Limited | Hydantoin derivatives useful as kv3 inhibitors |
US9193704B2 (en) | 2011-06-07 | 2015-11-24 | Autifony Therapeutics Limited | Hydantoin derivatives as KV3 inhibitors |
-
2012
- 2012-06-06 GB GBGB1209986.7A patent/GB201209986D0/en not_active Ceased
-
2013
- 2013-06-06 WO PCT/GB2013/051487 patent/WO2013182850A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2013182850A1 (en) | 2013-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1201819A1 (en) | Novel compounds | |
GB201207406D0 (en) | Novel compounds | |
HK1212985A1 (en) | Novel compounds | |
EP2922550A4 (en) | Novel compounds | |
HK1208826A1 (en) | Novel compounds | |
GB201212871D0 (en) | Novel compounds | |
EP2922547A4 (en) | Novel compounds | |
IL280595A (en) | Novel compounds | |
GB201209986D0 (en) | Novel compounds | |
GB201222711D0 (en) | Novel compounds | |
GB201207392D0 (en) | Novel compounds | |
GB201209670D0 (en) | Novel compounds | |
GB201212816D0 (en) | Novel compounds | |
GB201222435D0 (en) | Novel compounds | |
GB201222433D0 (en) | Novel compounds | |
GB201222419D0 (en) | Novel compounds | |
GB201222430D0 (en) | Novel compounds | |
GB201222393D0 (en) | Novel compounds | |
GB201219554D0 (en) | Novel compounds | |
GB201219472D0 (en) | Novel compounds | |
GB201217387D0 (en) | Novel compounds | |
GB201216551D0 (en) | Novel compounds | |
GB201216548D0 (en) | Novel compounds | |
GB201213023D0 (en) | Novel compounds | |
GB201211246D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |